Friday May 29, 2020 07:51

Heathcare Press Release : 14 Sep 2015

MEDICAL FAIR THAILAND 2015 opens its doors today Thailands largest event for the medical and health care industry showcases 600 companies from all over the world Heathcare—14 Sep 15

Ms. Supawan Teerarat, Vice President – Strategic and Business Development, Thailand Convention & Exhibition Bureau Dr. Kumpol Plussind, Vice President, Private Hospital Association Mr. Preecha Bhandtivej President, Thai Medical Device

Merck to Present New Data at the European Cancer Congress 2015 Reinforcing the Company#s Patient-Centric Focus Heathcare—14 Sep 15

DARMSTADT, Germany--14 Sep--PRNewswire/InfoQuest
ECC Abstract #: Avelumab*: 3090, 2749, 2364, 2630, 3110, 2398; Erbitux: 2120, 2112, 420, 2400, 2820; evofosfamide: 2312; tepotinib: 365, 2353, 3082, 369.

Merck will present new data on early- and late-stage compounds from its refocused oncology and immuno-oncology pipeline, as well as Erbitux(R) (cetuximab) data, at this year's European Cancer Congress (ECC), held in Vienna, Austria, from September 25-29, 2015.

These data reinforce the company's science-driven and patient-centric approach to developing new therapies that will help patients fight difficult-to-treat cancers such as pancreatic, non-small cell lung and urothelial."Our data at ECC 2015 demonstrate our oncology strategy in action, through external innovation and a focus on precision medicine to personalize treatment," said Luciano Rossetti, Head of Global Research & Development at Merck's biopharmaceutical business Merck Serono. "We are committed to understanding which patients will benefit most from our treatments, as this is a critical comp